Johnson & Johnson’s medical device division was again a weak link: revenues from the division fell 11% in its first quarter, to $6.26bn.
But as in Q4, unfavorable exchange rates did not help matters: on a constant currency basis, device sales were...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?